This may
explain why more deaths aren't prevented by breast cancer screening
Thus the LA Times titles an
article based on an essay by three cancer scientists, published in the New
England Journal of Medicine.
“The article starts:
“the incidence of metastatic breast cancer — the kind that has already spread to another
organ by the time it is found — has remained essentially unchanged since 1975.”
“The idea, of course is
to catch cancer before it can spread.”
As we read on, we may want to say instead, ..the idea has
been to catch it before it spreads. Not working so well for us.
The article's surprise is a
comparison of our BC non-success story with the success, believe it or not, of the prostate cancer screening situation. Catching prostate cancer early has improved amazingly since discovery of a blood test for an antigen specific to the prostate
– PSA. Metastatic prostate cancer has
been basically halved.
So far it seems there
is no similar antigen for breast cancer.
We have been screening, and screening, and our numbers don't change.
The essay suggests two
possible reasons why our BC situation fails to succeed.
I’m going to copy their
reasons direct from the LA Times:
“The first is that mammograms just
aren’t good enough to find metastatic breast cancers before they spread. If
there were a breast cancer equivalent of PSA — a biomarker that could be found
in blood — perhaps screening outcomes would be different.
A more likely explanation is that
breast cancer doesn’t necessarily start in one place and then spread to others.
Indeed, breast cancer researcher extraordinaire
Dr. Bernard Fisher argues that by the time the cancer can be
detected, it has already become a systemic disease.
To me, Dr.
Fisher, seems to be agreeing with the first explanation, seems to say the
starting cells are too little to find, and they’re on the move early.
But breast cancer may not start in just one place?!
I know our major hospitals basically seem to agree with Dana-Farber, the one I’ve quoted recently. D-F states "All breast cancers initially form inside the milk duct near the area where the duct meets the milk gland, or lobule..."
Yet the
essayists are not alone in thinking it's how the cells start and how they act. Their “more likely explanation” has been hinted at before.
Let’s go
back to another article:
https://www.nlm.nih.gov/medlineplus/news/fullstory_154216.htmlTHURSDAY, Aug. 20,
2015 (HealthDay News) Early Stage Breast Cancer Far From a Death Sentence: Study
See HEN BACKTALK post
"... AND MAMMOGRAM WARS" October 7, 2015
“… Narod (study
author) explained.:
" 'In all, 956 women in the study
ultimately died of breast cancer. Of those, 517 never had invasive
cancer in the breast after treatment seemed to cure their DCIS. That means that
the cancerous breast cells from their DCIS had escaped at some point and
survived in the lungs or bone, later developing into a deadly cancer' “ (Bolding mine)
"...seemed to cure their
DCIS." That stopped me in my tracks the first time I read it.
But Dr. Narod's explanation is right on point
with the essayists from Times/NEJM article.
He,insists that
DCIS cells escaped, probably before or during the original treatment,
and “survived in the lungs or bone."
DCIS cells escaped, probably before or during the original treatment,
and “survived in the lungs or bone."
Perhaps these two reports are only a tip
of the iceberg. But their bottom line
for us is this: that we’ve been mammogrammed, perhaps repeatedly, but perhaps...
AFTER the DCIS cell
train had already left the station, bound for the rest of our bodies.
More later on possible cancer cells in the blood
I wish you health.
http://www.latimes.com/science/sciencenow/la-sci-sn-breast-prostate-cancer-progression-20151028-story.html
No comments:
Post a Comment